Comparative Evaluation of Chlorhexidine, Herbal Mouthwash (Amarantha), and Probiotic Mouthwash (Oralvit) on Plaque Index: An Observational Study
DOI:
https://doi.org/10.48165/ajm.2026.9.01.1Keywords:
Chlorhexidine, Plaque, Probiotic MouthwashAbstract
Background: Dental plaque is the primary etiological factor for gingivitis and periodontal diseases. Mouthwashes are widely used as adjuncts to mechanical plaque control. Chlorhexidine (CHX) is the gold standard, whereas herbal and probiotic formulations are gaining popularity due to their safety and patient acceptance. Aim: To compare the Plaque Index (PI) reduction produced by 0.12% chlorhexidine, a herbal mouthwash (Amarantha), and a probiotic mouthwash (Oralvit Probiotic Anti-Plaque) in an in vivo population. Materials and Methods: An in vivo comparative study was conducted on 45 participants aged 18–40 years with mild to moderate plaque accumulation. Subjects were randomly divided into three groups: Group A (0.12% CHX), Group B (Amarantha herbal mouthwash), and Group C (Oralvit probiotic mouthwash). Plaque Index (Silness & Löe, 1964) was recorded at baseline, day 7, day 14, and day 28. Results: All groups showed significant reductions in plaque scores over time. CHX demonstrated the most rapid reduction at day 7, while the herbal and probiotic groups showed progressive reductions, with comparable efficacy to CHX by day 28. Conclusion: Chlorhexidine remains the most effective short-term antiplaque agent. Herbal and probiotic mouthwashes show comparable plaque reduction over longer durations and may serve as effective alternatives for long-term use.References
Jakubovics NS, Goodman SD, Mashburn-Warren L, Stafford GP, Cieplik F. The dental plaque biofilm matrix. Periodontol 2000. 2021;86(1):32-56.
Flemming HC, Wingender J. The biofilm matrix. Nat Rev Microbiol. 2010;8:623-633.
Valm AM. The structure of dental plaque microbial communities in the transition from health to dental caries and periodontal disease. J Mol Biol. 2019;431(16):2957-2969.
Brookes ZLS, Bescos R, Belfield LA, Ali K, Roberts A. Current uses of chlorhexidine for management of oral disease: A narrative review. J Dent. 2020;103:103497.
Poppolo Deus F, Ouanounou A. Chlorhexidine in dentistry: Pharmacology, uses, and adverse effects. Int Dent J. 2022;72(3):269-277.
Ediga S, Gulati R, Chokotiya H, Modi M, Sethi V, Kashyap SK. Evaluating the effectiveness of Amarantha and chlorhexidine mouthwashes in chronic generalized gingivitis: A randomized clinical trial. J Pharm Bioallied Sci. 2024;16(Suppl 4):S3437-S3439.
Blais L, Auclair-Ouellet N, Tremblay A, Binda S. Effect of the Darolac® (Oralis SB®) probiotic formulation on oral health: A narrative review. Microorganisms. 2025;13(2):408.
Thangavelu A, Kaspar SS, Kathirvelu RP, Srinivasan B, Srinivasan S, Sundram R. Chlorhexidine: An elixir for periodontics. J Pharm Bioallied Sci. 2020;12(Suppl 1):S57-S59.
Greenstein G, Berman C, Jaffin R. Chlorhexidine: An adjunct to periodontal therapy. J Periodontol. 1986;57:370-377.
Nipanikar S, Agnihotri S, Panicker S, Shelke N. Evaluation of antimicrobial (in vitro) activity of Amarantha herbal mouthwash. Int J Sci Res. 2020;9:1624-1626.
Alhallak E, Kouchaje C, Hasan A, Makieh R. Evaluation of the effectiveness of probiotic mouthwashes in reducing dental plaque in primary and permanent teeth: A randomized clinical trial. Cureus. 2022;14(8):e28125.

